Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022 Read more
New analyses of two AZD7442 COVID-19 phase-III trials in high-risk populations confirm robust efficacy and long-term prevention Read more
India has robust manufacturing capability with sufficient skilled manpower to foster innovation Read more
Approved antibiotics and those under clinical development are insufficient to arrest AMR: Rex Clements, Centrient Pharmaceuticals Read more
Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from US FDA Read more
Alembic Pharmaceuticals’s joint venture Aleor Dermaceuticals receives US FDA final approval for Mupirocin Cream USP, 2% Read more
Cipla launches Spirofy, strengthens its lung leadership position by facilitating early diagnosis for COPD1 Read more